We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-2.71%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$55.4M
AUM Growth
+$2.06M
Cap. Flow
+$13.9M
Cap. Flow %
25.13%
Top 10 Hldgs %
80.61%
Holding
29
New
10
Increased
2
Reduced
3
Closed
7

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.43M
2
CVS icon
CVS Health
CVS
+$2.96M
3
WBA
Walgreens Boots Alliance
WBA
+$2.68M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$2.02M
5
COR icon
Cencora
COR
+$1.72M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$2.17M
2
GSK icon
GSK
GSK
+$823K
3
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
+$290K

Sector Composition

Rank Sector Weight
1 Healthcare 57.5%
2 Miscellaneous 41.28%
3 Consumer Staples 1.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
CALL
Johnson & Johnson
JNJ
$640B
– –
-25,000
Closed -$3.48M
LGND icon
27
PUT
Ligand Pharmaceuticals
LGND
$5.67B
– –
-40,075
Closed -$2.85M
PFE icon
28
Pfizer
PFE
$160B
– –
-52,700
Closed -$2.17M
GWPH
29
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-6,000
Closed -$1.03M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2019 Portfolio in Review

As of Q3 2019, Healthcare Value Capital held 29 positions worth $55.4M, up 3.9% from $53.3M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Healthcare Value Capital deployed $13.9M of net new capital in Q3 2019, opening 10 new positions and adding to 2 existing holdings. Its largest new stake was AbbVie: 50,000 shares worth $3.79M.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, up from 36% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was GSK, an estimated $823K trimmed.

  • Healthcare Value Capital's largest Q3 2019 buy was AbbVie: 50,000 shares worth $3.79M.
  • Healthcare Value Capital's biggest Q3 2019 reduction was GSK, cutting an estimated $823K.
  • Healthcare Value Capital fully exited Pfizer in Q3 2019, selling an estimated $2.17M.
  • Healthcare Value Capital's ten largest holdings make up 81% of its $55.4M portfolio in Q3 2019.
  • Healthcare Value Capital opened 10 new positions and closed 7 in Q3 2019.
  • Healthcare Value Capital's portfolio value rose 3.9% quarter-over-quarter to $55.4M.

Based on Healthcare Value Capital's 13F filing for Q3 2019, filed 14 Nov 2019.